Efficacy of Calmmax Cream in the Management of Chronic Uremic Pruritus

NCT02032537•Shaare Zedek Medical Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Calmmax Cream on UP in CKD Patients.

Interventions

Callmax cream application over affected skin

Placebo

Locations

Israel

Locations (1)

Shaare Zedek Medical Center

Jerusalem, Israel

Key Dates

Start Date

November 1, 2014

Primary Completion Date

November 1, 2015

Completion Date

May 1, 2016

Last Updated

January 10, 2014

Contacts

Linda Shavit, Dr

CONTACT

97226555111 lshavit@szmc.org.il

Sponsors

Lead Sponsor

Shaare Zedek Medical Center

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 10, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions